창상 접촉층 피복재 시장 규모, 점유율, 동향 분석 : 제품별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

The global wound contact layer dressing market size was valued at USD 529.3 million in 2025 and is projected to grow from USD 597.1 million in 2026 to USD 1,400 million in 2033, at a CAGR of 12.8% from 2026 to 2033. The North America dominated the market, accounting for a revenue share of 45.0% in 2025. The market is primarily driven by factors such as the rising number of chronic diseases and conditions that impair wound-healing capacity, and the rising number of accidents requiring effective wound-healing methods. Growing focus on the development of composite dressings, increasing investments in emerging economies, and rapid technological development of wound dressings offer significant growth opportunities for the market.

Wound contact layer dressings incorporate advanced materials such as silicone and hydrogels. These materials are specifically designed to provide gentle adhesion while minimizing trauma to the wound bed during dressing changes. In addition, several products incorporate technologies such as perforations and microstructured surfaces that enhance moisture balance and support the wound-healing process. Demand for wound contact layer dressings is being driven by the rising prevalence of chronic diseases and conditions that impair the body's ability to heal wounds effectively. Both chronic and surgical wounds can significantly delay healing.

Factors such as the growing elderly population, the increasing incidence of traumatic injuries, the rising number of surgical procedures, and the growing prevalence of conditions such as obesity and diabetes collectively contribute to the increasing burden of chronic wounds. According to the International Diabetes Federation (IDF) Diabetes Atlas, 11th Edition (2025), approximately 589 million adults aged 20-79 years were living with diabetes globally in 2024, and this number is projected to reach 853 million by 2050. The rising diabetes burden significantly increases the incidence of diabetic foot ulcers and other chronic wounds, thereby supporting demand for wound contact layer dressings.

Furthermore, the increasing prevalence of obesity represents another key factor supporting market expansion due to its strong association with chronic wounds and lower-extremity complications. Individuals with obesity are at a greater risk of developing pressure ulcers because reduced vascular activity within adipose tissue can impair tissue perfusion and delay wound healing. In addition, limited mobility may hinder frequent repositioning, increasing susceptibility to pressure-related injuries. Skin folds can also create warm, moist environments that promote microbial growth and increase the risk of skin breakdown. As a result, the growing prevalence of obesity is expected to stimulate demand for advanced wound care products, including wound contact layer dressings, thereby supporting market growth.

Moreover, countries such as the U.S. and Canada have witnessed increasing hospital admissions in recent years due to the high prevalence of chronic diseases and severe injuries. According to the Centers for Disease Control and Prevention (CDC) (2025), chronic conditions such as heart disease, cancer, diabetes, obesity, and hypertension continue to account for a significant share of disease burden and healthcare spending in the U.S. The growing prevalence of chronic diseases and associated wound complications is expected to support the adoption of advanced wound care products, including wound contact layer dressings.

Global Wound Contact Layer Dressing Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities across each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global wound contact layer dressing market report based on product, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

Antimicrobial

Non-antimicrobial

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

Hospitals

Outpatients

Home Healthcare

Research & Manufacturing

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

North America

• U.S.
• Canada

Europe

• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Thailand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• South Africa
• Saudi Arabia
• UAE
• Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. End-use
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. End-use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Wound Contact Layer Dressing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
    • 3.3.1.1. Increasing prevalence of chronic diseases impacting wound healing capabilities
    • 3.3.1.2. Rising number of accidents
    • 3.3.1.3. Increase in number of healthcare centers such as ASCs
  • 3.3.2. Market restraint analysis
    • 3.3.2.1. High cost of advanced wound care products
• 3.4. Wound Contact Layer Dressing Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PEST Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic landscape
    • 3.4.2.3. Social landscape
    • 3.4.2.4. Technological landscape

Chapter 4. Wound Contact Layer Dressing Market: Product Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Antimicrobial
  • 4.1.2. Non-antimicrobial
• 4.2. Product Market Share, 2025 & 2033
• 4.3. Segment Dashboard
• 4.4. Wound Contact Layer Dressing Market by Product Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5.1. Antimicrobial
    • 4.5.1.1. Antimicrobial market estimates and forecast 2021 to 2033 (USD Million)
  • 4.5.2. Non-antimicrobial
    • 4.5.2.1. Non-antimicrobial market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Wound Contact Layer Dressing Market: End-user Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Hospitals
  • 5.1.2. Outpatient
  • 5.1.3. Home Healthcare
  • 5.1.4. Research & Manufacturing
• 5.2. End-user Market Share, 2025 & 2033
• 5.3. Segment Dashboard
• 5.4. Wound Contact Layer Dressing Market by End-user Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5.1. Hospitals
    • 5.5.1.1. Hospitals market estimates and forecast 2021 to 2033, (USD Million)
  • 5.5.2. Outpatient
    • 5.5.2.1. Outpatient market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5.3. Home Healthcare
    • 5.5.3.1. Outpatient market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5.4. Research & Manufacturing
    • 5.5.4.1. Outpatient market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Wound Contact Layer Dressing Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2025 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Regional Market Share and Leading Players, 2025
  • 6.4.1. North America
  • 6.4.2. Europe
  • 6.4.3. Asia Pacific
  • 6.4.4. Latin America
  • 6.4.5. Middle East and Africa
• 6.5. Market Estimate & Forecasts and Trend Analysis, 2021 to 2033
• 6.6. North America
  • 6.6.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 6.6.2. U.S.
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Reimbursement scenario
    • 6.6.2.4. U.S. market estimates and forecasts, 2021 - 2033
  • 6.6.3. Canada
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Reimbursement scenario
    • 6.6.3.4. Canada market estimates and forecasts, 2021 - 2033
• 6.7. Europe
  • 6.7.1. UK
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework
    • 6.7.1.3. Reimbursement scenario
    • 6.7.1.4. UK market estimates and forecasts, 2021 - 2033
  • 6.7.2. Germany
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Reimbursement scenario
    • 6.7.2.4. Germany market estimates and forecasts, 2021 - 2033
  • 6.7.3. France
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Reimbursement scenario
    • 6.7.3.4. France market estimates and forecasts, 2021 - 2033
  • 6.7.4. Italy
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework
    • 6.7.4.3. Reimbursement scenario
    • 6.7.4.4. Italy market estimates and forecasts, 2021 - 2033
  • 6.7.5. Spain
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework
    • 6.7.5.3. Reimbursement scenario
    • 6.7.5.4. Spain market estimates and forecasts, 2021 - 2033
  • 6.7.6. Denmark
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework
    • 6.7.6.3. Reimbursement scenario
    • 6.7.6.4. Denmark market estimates and forecasts, 2021 - 2033
  • 6.7.7. Sweden
    • 6.7.7.1. Key country dynamics
    • 6.7.7.2. Regulatory framework
    • 6.7.7.3. Reimbursement scenario
    • 6.7.7.4. Sweden market estimates and forecasts, 2021 - 2033
  • 6.7.8. Norway
    • 6.7.8.1. Key country dynamics
    • 6.7.8.2. Regulatory framework
    • 6.7.8.3. Reimbursement scenario
    • 6.7.8.4. Norway market estimates and forecasts, 2021 - 2033
• 6.8. Asia Pacific
  • 6.8.1. Japan
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework
    • 6.8.1.3. Reimbursement scenario
    • 6.8.1.4. Japan market estimates and forecasts, 2021 - 2033
  • 6.8.2. India
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Reimbursement scenario
    • 6.8.2.4. India market estimates and forecasts, 2021 - 2033
  • 6.8.3. China
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Reimbursement scenario
    • 6.8.3.4. China market estimates and forecasts, 2021 - 2033
  • 6.8.4. South Korea
    • 6.8.4.1. Key country dynamics
    • 6.8.4.2. Regulatory framework
    • 6.8.4.3. Reimbursement scenario
    • 6.8.4.4. South Korea market estimates and forecasts, 2021 - 2033
  • 6.8.5. Australia
    • 6.8.5.1. Key country dynamics
    • 6.8.5.2. Regulatory framework
    • 6.8.5.3. Reimbursement scenario
    • 6.8.5.4. Australia market estimates and forecasts, 2021 - 2033
  • 6.8.6. Thailand
    • 6.8.6.1. Key country dynamics
    • 6.8.6.2. Regulatory framework
    • 6.8.6.3. Reimbursement scenario
    • 6.8.6.4. Thailand market estimates and forecasts, 2021 - 2033
• 6.9. Latin America
  • 6.9.1. Brazil
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Regulatory framework
    • 6.9.1.3. Reimbursement scenario
    • 6.9.1.4. Brazil market estimates and forecasts, 2021 - 2033
  • 6.9.2. Mexico
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework
    • 6.9.2.3. Reimbursement scenario
    • 6.9.2.4. Mexico market estimates and forecasts, 2021 - 2033
  • 6.9.3. Argentina
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework
    • 6.9.3.3. Reimbursement scenario
    • 6.9.3.4. Argentina market estimates and forecasts, 2021 - 2033
• 6.10. MEA
  • 6.10.1. South Africa
    • 6.10.1.1. Key country dynamics
    • 6.10.1.2. Regulatory framework
    • 6.10.1.3. Reimbursement scenario
    • 6.10.1.4. South Africa market estimates and forecasts, 2021 - 2033
  • 6.10.2. Saudi Arabia
    • 6.10.2.1. Key country dynamics
    • 6.10.2.2. Regulatory framework
    • 6.10.2.3. Reimbursement scenario
    • 6.10.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033
  • 6.10.3. UAE
    • 6.10.3.1. Key country dynamics
    • 6.10.3.2. Regulatory framework
    • 6.10.3.3. Reimbursement scenario
    • 6.10.3.4. UAE market estimates and forecasts, 2021 - 2033
  • 6.10.4. Kuwait
    • 6.10.4.1. Key country dynamics
    • 6.10.4.2. Regulatory framework
    • 6.10.4.3. Reimbursement scenario
    • 6.10.4.4. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
  • 7.1.1. Innovators
• 7.2. Vendor Landscape
  • 7.2.1. List of key distributors and channel partners
  • 7.2.2. Key customers
  • 7.2.3. Key company market share analysis, 2025
  • 7.2.4. Hollister Incorporated
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. 3M
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. Cardinal Health
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. Advanced Medical Solutions Limited
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. Coloplast Ltd,
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives
  • 7.2.9. Cutimed (a brand of Essity).
    • 7.2.9.1. Company overview
    • 7.2.9.2. Financial performance
    • 7.2.9.3. Product benchmarking
    • 7.2.9.4. Strategic initiatives
  • 7.2.10. Paul Hartmann
    • 7.2.10.1. Company overview
    • 7.2.10.2. Financial performance
    • 7.2.10.3. Product benchmarking
    • 7.2.10.4. Strategic initiatives
  • 7.2.11. BSN Medical
    • 7.2.11.1. Company overview
    • 7.2.11.2. Financial performance
    • 7.2.11.3. Product benchmarking
    • 7.2.11.4. Strategic initiatives
  • 7.2.12. Smith + Nephew
    • 7.2.12.1. Company overview
    • 7.2.12.2. Financial performance
    • 7.2.12.3. Product benchmarking
    • 7.2.12.4. Strategic initiatives
  • 7.2.13. Medline Industries
    • 7.2.13.1. Company overview
    • 7.2.13.2. Financial performance
    • 7.2.13.3. Product benchmarking
    • 7.2.13.4. Strategic initiatives
  • 7.2.14. Molnlycke Health Care
    • 7.2.14.1. Company overview
    • 7.2.14.2. Financial performance
    • 7.2.14.3. Product benchmarking
    • 7.2.14.4. Strategic initiatives